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The osmosensitive transcription factor nuclear factor of activated T-cells (NFAT) 5, also
known as tonicity enhancer binding protein (TonEBP), has been associated with the
development of a variety of tumor entities, among them breast cancer, colon carcinoma,
and melanoma. The aim of the present study was to determine whether NFAT5 is also
involved in the development of renal cell carcinoma (RCC). The most common type of
RCC, the clear cell RCC, originates from the proximal convoluted tubule. We tested
our hypothesis in the clear cell RCC cell line CaKi-1 and the non-cancerous proximal
tubule cell line HK-2, as control. Basal expression of NFAT5 and NFAT5 activity in CaKi-1
cells was several times higher than in HK-2 cells. Osmotic stress induced an increased
NFAT5 activity in both CaKi-1 and HK-2 cells, again with significantly higher activities
in CaKi-1 cells. Analysis of NFAT5-regulating signaling pathways in CaKi-1 cells revealed
that inhibition of the MAP kinases p38, c-Jun-terminal kinase (JNK) and extracellular
regulated kinase (ERK) and of the focal adhesion kinase (FAK) partially blunted NFAT5
activity. FAK and ERK were both constitutively active, even under isotonic conditions,
which may contribute to the high basal expression and activity of NFAT5 in CaKi-1 cells.
In contrast, the MAP kinases p38 and JNK were inactive under isotonic conditions and
became activated under osmotic stress conditions, indicating that p38 and JNK mediate
upregulation of NFAT5 activity under these conditions. siRNA-mediated knockdown of
NFAT5 in CaKi-1 cells reduced the expression of S100A4, a member of the S100 family
of proteins, which promotes metastasis. Knockdown of NFAT5 was accompanied by a
significant decrease in proliferation and migration activity. Taken together, our results
indicate that NFAT5 induces S100A4 expression in CaKi-1 cells, thereby playing an
important role in RCC proliferation and migration.
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INTRODUCTION
Renal cell carcinoma (RCC) was the sixth and eighth most com-
mon malignancy among men and women, respectively, in 2012,
contributing to almost 14,000 deaths in the US (Siegel et al.,
2012). The most common type of RCC, the clear cell RCC orig-
inates from the proximal convoluted tubule. Metastatic RCC in
particular has a very poor prognosis due to the high resistance of
the tumors to conventional radiation-, immune-, and chemother-
apies. To develop new therapeutic strategies, significant efforts
have been made in the last two decades to identify the genetic
basis of clear cell RCC. In most cases of sporadic RCC, deletion
or mutation of the tumor suppressor gene Von-Hippel-Lindau
(VHL) can be detected (Linehan et al., 2003). Under normoxic
conditions, VHL catalyzes ubiquitination and, hence, degradation
of the transcription factor hypoxia-inducible factor α (HIF-α).
Loss of VHL results in accumulation of HIF-α even under nor-
moxic conditions and downstream induction of diverse growth
and angiogenic factors that contribute to malignant transforma-
tion of tubular epithelial cells (Patel et al., 2006). Based on these
observations, several new pharmaceutical agents that target the
involved signaling pathways have been approved in recent years
(Motzer, 2011). Although these agents increase the therapeutic
options in the treatment of metastatic RCC, continuous research
is necessary to gain a better insight to the biological basis of car-
cinogenesis and metastasis of renal tubular cells and to identify
potential targets for new therapeutic strategies.
The aim of the present study was to determine whether the
osmosensitive transcription factor nuclear factor of activated T-
cells (NFAT) 5, also known as tonicity enhancer binding protein
(TonEBP), is involved in the development of RCC. The NFAT
protein family consists of five members (NFAT1-5) that con-
tain a DNA-binding domain with structural similarity to the
Rel-homology-region of NF-κB (Muller and Rao, 2010). While
activity of NFAT1-4 is regulated by calcineurin, NFAT5 activity
is modulated under hyperosmotic conditions at various lev-
els: increased expression, increased transcriptional activity, and
increased nuclear localization. Upon activation, NFAT5 binds to
tonicity enhancer (TonE) elements in the regulatory region of
target genes to stimulate transcription (Cheung and Ko, 2013).
NFAT5 was discovered originally in the renal medulla, where it
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drives the expression of osmoprotective genes such as betaine-
GABA-transporter-1 (BGT-1) (Miyakawa et al., 1998), aldose
reductase (AR) (Miyakawa et al., 1999), sodium-myo-inositol
transporter (Smit) (Miyakawa et al., 1999), taurine transporter
(TauT) (Zhang et al., 2003) or heat shock protein (HSP) 70 (Woo
et al., 2002), as well as genes that are part of the urinary con-
centrating mechanism, such as aquaporin-2 (AQP-2) and urea
transporter-A (UT-A) (Han et al., 2004). Besides this function in
the kidney, NFAT5 also plays important roles in other cells and
tissues, partly in a tonicity-independent manner, during embry-
onic development, cell differentiation, inflammatory processes,
and cellular stress response (Halterman et al., 2012).
Various reports have also suggested involvement of NFAT5 in
the pathogenesis of various tumor entities, such as non-small cell
lung cancer (Zhong et al., 2004; Mijatovic et al., 2006), melanoma
(Levy et al., 2010), leiomyoma (McCarthy-Keith et al., 2011),
breast cancer (Jauliac et al., 2002; Chen et al., 2009; Germann
et al., 2012), or colon carcinoma (Chen et al., 2011; Slattery
et al., 2011; Alvarez-Diaz et al., 2012). In colon and breast car-
cinoma cells NFAT5 drives the expression of the pro-metastatic
factor S100A4, also known asmetastasin (Chen et al., 2009, 2011).
S100A4 belongs to the family of S100 proteins that consists of
at least 21 calcium-binding, low-molecular-weight (10–12 kDa)
proteins with no known enzymatic activity. S100 proteins form
homo- or heterodimers that bind to various target proteins,
thereby modulating their activities. Many studies indicated a
pathophysiological role for S100A4 in the development of can-
cer by promoting proliferation, angiogenesis, cell motility and
invasiveness (Garrett et al., 2006). S100A4 binds to several target
proteins, among them the tumor suppressor p53 and the non-
muscle myosin IIa. Recent studies suggest that S100A4 also plays
a role in the development of RCC andmay be useful as prognostic
marker (Bandiera et al., 2009; Lopez-Lago et al., 2010;Wang et al.,
2012; Yang et al., 2012).
In the present study, we provide evidence that NFAT5
and S100A4 are expressed abundantly in RCC cells, proba-
bly due to the constitutive activation of the extracellular reg-
ulated kinase (ERK). Under hyperosmotic conditions, NFAT5
is upregulated and, in turn, induces enhanced expression
of S100A4. Knockdown of NFAT5 blunts S100A4 expression
and also decreased proliferation and migration activity of the
cells.
METHODS
MATERIALS
Pharmacological inhibitors SB202190, SP600125, U0126, SrcI-
1, and PF-228 were obtained from Sigma (Deisenhofen,
Germany). Anti-NFAT5 antibody, anti-Src antibody, anti-FAK
antibody, and anti-phospho-FAK antibody were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); anti-actin antibody was
from Sigma; anti-p38, anti-phospho-p38, anti-ERK1/2, anti-
phospho-ERK1/2, anti-JNK, anti-phospho-JNK, and horseradish
peroxidase-conjugated anti-rabbit IgG were purchased from Cell
Signaling (Beverly, MA, USA); anti-phospho–Src antibody was
from Abgent (Suzhou, China); anti-S100A4 antibody was from
Spring Bioscience (Pleasanton, CA, USA). Accell SMARTpool
siRNA constructs for knockdown of NFAT5 or S100A4, and
Accell non-targeting siRNA (#2) were obtained from Thermo
Fisher Scientific (Epsom, UK). Unless otherwise indicated, other
reagents were purchased from Biomol (Hamburg, Germany),
Biozol (Eching, Germany), Carl Roth (Karlsruhe, Germany), or
Sigma.
CELL CULTURE
Immortalized human proximal tubule cells HK-2 (ATCC
CRL-2190) and clear cell renal carcinoma cells CaKi-1 (ATCC
HTB-46) were cultured in RPMI 1640 supplemented with 10%
fetal bovine serum (FBS; Biochrom, Berlin, Germany), 100
units/ml penicillin, and 100μg/ml streptomycin (Invitrogen,
Karlsruhe, Germany). Cells were grown at 37◦C in a humidified
atmosphere (95% air/5% CO2). For experiments involving
pharmacological inhibitors, cells were preincubated for 30min
with the appropriate inhibitor; medium osmolality was increased
by addition of NaCl.
qRT-PCR ANALYSIS
For determination of NFAT5, S100A4, AR, and β-Actin mRNA
expression levels, the total RNA from HK-2 or CaKi-1 cells
was prepared by adding TRIFAST Reagent (Peqlab, Erlangen,
Germany). The primers (Metabion, Martinsried, Germany) used
in this experiment are:
NFAT5_fw: 5′- AAT CGC CCA AGT CCC TCT AC -3′;
NFAT5_rev: 5′- GGT GGT AAA GGA GCT GCA AG -3′;
Actin_fw: 5′- CCA ACC GCG AGA AGA TGA -3′;
Actin_rev: 5′- CCA GAG GCG TAC AGG GAT AG -3′;
S100A4_fw: 5′-CGC TTC TTC TTT CTT GGT TTG-3′;
S100A4_rev: 5′-GAG TAC TTG TGG AAG GTG GAC A-3′;
AR_fw: 5′ATC CGA GCC AAG CAC AAT AA -3′;
AR_rev: 5′-AGC AAT GCG TTC TGG TGT CA -3′
Experiments were caried out on a Roche LightCycler 480
using the SensiMix SYBR One-Step Kit (Bioline, Luckenwalde,
Germany) according to the manufacturer’s recommendations.
Specificity of PCR product formation was confirmed by melting
point analysis and by agarose gel electrophoresis.
IMMUNOBLOT ANALYSIS
Aliquots (10–30μg protein) were subjected to sodium dode-
cylsulphate polyacrylamide gelelectrophoresis (SDS-PAGE) and
blotted onto nitrocellulose membranes (Amersham Pharmacia
Biotech, Buckinghamshire, UK). Non-specific binding sites were
blocked with 5% non-fat dry milk in PBS containing 0.1%
Tween-20 (PBS-T) at room temperature for 1 h. Samples were
incubated with primary antibodies in PBS-T containing 5%
non-fat dry milk over night at 4◦C. Subsequently, the blots were
washed 3 times with PBS-T for 5min each and the membranes
then incubated with appropriate secondary antibody at room
temperature for 1 h in PBS-T containing 5% non-fat dry milk.
After washing with PBS-T 3 times for 5min each, immunocom-
plexes were visualized by enhanced chemiluminescence (Pierce,
Rockford, IL, USA).
REPORTER GENE ASSAYS
Activation of NFAT5 in response to hyperosmolality was assessed
using the secreted alkaline phosphatase system (SEAP), with
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a reporter construct, in which the SEAP open reading frame
is under control of two TonE sites (Neuhofer et al., 2007).
As transfection control, the vector pcDNA3-lacZ, expressing β-
galactosidase under the control of the constitutive active CMV
promoter, was co-transfected. For transfection, CaKi-1 or HK-
2 cells were grown to ∼80% confluency, trypsinated, washed
in PBS and ∼106 cells were finally resuspended in 200μl
modified HBS electroporation buffer (0.5% HEPES, 1% glu-
cose, 0.5% Ficoll, 5mM NaCl, 135mM KCl, 2mM MgCl2,
pH 7.4) together with 10μg reporter vector. Electroporation
was carried out with a Gene Pulser Xcell Electroporation
System (Biorad, Hercules, CA, USA) at 140V and 1000 μF
(exponential decay pulse) in a 2-mm cuvette and the cells
seeded immediately thereafter in 96-well plates. After growing
to confluency, the cells were treated as indicated and SEAP
activity in the medium determined as described in detail else-
where (Neuhofer et al., 2007). SEAP activity was normalized
to β-galactosidase activity to adjust for uneven transfection of
cells.
KNOCKDOWN OF NFAT5 AND S100A4
CaKi-1 cells were grown to ∼80% confluency, trypsinated,
washed in PBS and finally resuspended in 100μl modified
HBS electroporation buffer (see above) containing 2μM of
NFAT5 siRNA, S100A4 siRNA or unspecific Accell non-targeting
siRNA (#2), as control. Electroporation was carried out as
described above. Cells were incubated for 5 days, and knock-
down efficiency was determined by qRT-PCR or by Western blot
analysis.
PROLIFERATION AND SURVIVAL ASSAY
For proliferation assays, CaKi-1 cells were transfected with
NFAT5-specific, S100A4-specific, or unspecific (control)-siRNA
constructs by electroporation as described above. After the elec-
tric pulse, cells were seeded immediately in 96-well plates at a den-
sity of ∼104 cells/well. After 4 days, viable cells were determined
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay. For this purpose, cells were incubated with
MTT (final concentration 0.5mg/ml in growth medium) for
2 h at 37◦C. Thereafter, growth medium was removed and for-
mazan crystals were solubilized in 200μl acidified isopropanol
and absorption was rmeasured at 570 nm. For cell survival
assays, cells were treated as described above, but after 4 days
the medium osmolality was raised to 600mosmol/kg H2O by
addition of NaCl, and cells were incubated for an additional
24 h. Thereafter, viable cells were determined by MTT assay as
described.
SCRATCH ASSAY
Cell migration was analyzed using the in vitro scratch assay (Liang
et al., 2007), also known as the wound healing assay. CaKi-1
cells at ∼80% confluency were treated for 5 days with Accell
SMARTpool NFAT5 siRNA, Accell SMARTpool S100A4 siRNA,
or unspecific Accell non-targeting siRNA (#2), as control, with a
final concentration of 1000 nM in Accell delivery medium, con-
taining 2% FCS, in accordance with the manufacturer’s recom-
mendations. During the 5-days incubation period, cells reached
confluency. Subsequently, Accell delivery medium was replaced
by RPMI 1640 medium + 10% FCS and the cell momolayer
was “scratched” with a 10μl pipette tip. Cell migration to
close the scratch was monitored by capturing images in regular
intervals.
STATISTICAL ANALYSES
Data are expressed as means ± s.e.m. The significance of differ-
ences between themeans was assessed by Student’s t-test. P< 0.05
was regarded as significant. All experiments were performed at
least 3 times and representative results are shown.
RESULTS
NFAT5 AND NFAT5 TARGET GENES ARE EXPRESSED ABUNDANTLY IN
RENAL CARCINOMA CELLS
The cell line CaKi-1 was used as model for metastatic clear cell
RCC. As non-cancerous control cells, the proximal tubule cell
line HK-2 was used. Expression of NFAT5 in CaKi-1 and HK-2
cells was determined at both the mRNA (Figure 1A) and pro-
tein (Figure 1B) levels. NFAT5 levels were significantly higher in
CaKi-1 cells compared to HK-2 cells. In both cell lines, NFAT5
expression increased during hyperosmotic stress (Figures 1A,B),
whilst again expression levels were significantly higher in CaKi-
1 cells. Expression of S100A4 was almost completely absent in
HK-2 cells, while substantial amounts were present in CaKi-1
cells. Under hyperosmotic stress conditions, S100A4 expression
in CaKi-1 cells increased further. As control, we also evalu-
ated expression levels of the well-defined NFAT5 target gene
AR. In accordance with the results above, expression levels of
AR were also enhanced in CaKi-1 cells, presumably due to
increased NFAT5 activity. Cellular activity of NFAT5 in CaKi-
1 and HK-2 cells was assayed using a TonE-driven reporter
vector. Cells, transiently transfected with the reporter con-
struct, were incubated for 24 h in iso- or hyperosmotic medium.
Basal NFAT5 activities under isoosmotic conditions were sig-
nificantly higher in CaKi-1 cells (Figure 1C). Under hyperos-
motic conditions, NFAT5 activity increased approximately 10
times in both cell types, and hence was significantly higher in
CaKi-1 cells, which is in accordance with the higher expres-
sion levels of the NFAT5 target genes S100A4 and AR in these
cells.
KNOCKDOWN OF NFAT5 BLUNTS S100A4 EXPRESSION IN CaKi-1 CELLS
To confirm that NFAT5 regulates the expression of S100A4
in CaKi-1 cells, we knocked down NFAT5 in CaKi-1 cells.
Transfection of the cells with a NFAT5-specific siRNA construct
resulted in an approximately 80% reduction of NFAT5 expres-
sion compared with cells transfected with an unspecific control
siRNA (Figure 2). NFAT5 knockdown was accompanied by sig-
nificantly reduced S100A4 expression, both under isosmotic and
hyperosmotic conditions (Figure 2). Accordingly, the expression
of the designated NFAT5 target gene AR was also significantly
decreased in NFAT5-knockdown cells. We also performed siRNA-
mediated knockdown of S100A4; as expected, this maneuver had
no significant effect on expression of NFAT5 or AR. These results
suggest strongly that S100A4 expression in CaKi-1 cells is under
the control of NFAT5.
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FIGURE 1 | Expression of NFAT5 and NFAT5 target genes in CaKi-1 and
HK-2 cells. CaKi-1 cells, as model for clear cell renal cell carcinoma, or HK-2
cells, as proximal tubular control cells, were kept in isoosmotic medium (;
300 mosm/kg H2O) or were exposed to hyperosmotic medium (;
500mosm/kg H2O). Medium osmolality was elevated by addition of NaCl. (A)
Cells were incubated for 6 h (for determination of NFAT5 transcription) or 16 h
(for determination of S100A4 and AR transcription). Thereafter, RNA was
extracted and the abundance of NFAT5, S100A4, AR, and β-actin mRNA
transcripts determined by qRT-PCR as described in Methods. Relative mRNA
abundance of NFAT5, S100A4, or AR was normalized to that of β-actin to
correct for differences in RNA input. Data are means ± s.e.m. for n = 4 per
point; #P < 0.05 vs. HK-2 isoosmotic medium; ∗P < 0.05 vs. HK-2
hyperosmotic medium. (B) Cells were incubated for 24 h and subsequently
processed for immunoblotting to determine expression of NFAT5, S100A4,
and AR as described in Methods. To demonstrate comparable protein
loading, the blots were also probed for β-actin. Representative blots from 4
independent experiments are shown. (C) Cells were transfected transiently
with a reporter construct in which the SEAP gene is under control of two
TonE sites. After 24 h incubation in iso- or hyperosmotic medium, SEAP
activity was measured as described in Methods. Data are means ± s.e.m. for
n = 4 per point; #P < 0.05 vs. HK-2 isoosmotic medium; ∗P < 0.05 vs. HK-2
hyperosmotic medium.
KNOCKDOWN OF NFAT5 AND S100A4 DECREASES PROLIFERATION
AND MIGRATION OF CaKi-1 CELLS
S100A4 is known to stimulate proliferation and metastasis in
renal carcinoma cells (Yang et al., 2013). In the knockdown exper-
iments described above, we noticed decelerated growth of CaKi-1
cells transfected with NFAT5- or S100A4-specific siRNA, presum-
ably due to downregulation of S100A4. To quantify this effect,
we transfected CaKi-1 cells with NFAT5-specific siRNA, S100A4-
specific siRNA or unspecific control siRNA, let the cells grow
for 96 h in a 96-well plate and determined the number of viable
cells by MTT assay. As shown in Figure 3A, NFAT5 siRNA and
S100A4 siRNA had significant inhibitory effects on CaKi-1 cell
proliferation.
Next, the effect of NFAT5- and S100A4-knockdown on the
migratory capacity of cells was evaluated using the in vitro scratch
assay (Liang et al., 2007). For this purpose, a scratch was created
in a confluent monolayer and cell migration to close the scratch
was observed under the microscope. As can be seen in Figure 3B,
knockdown of NFAT5 or S100A4 clearly decreased the migration
ability of CaKi-1 cells.
Finally, the effect of NFAT5- and S100A4-knockdown on cell
survival during osmotic stress was examined. Confluent cells
were exposed to hyperosmotic conditions (600 mosm/kg H2O)
for 24 h and cell survival determined by MTT assay. Compared
with control cells incubated under isosmotic conditions, ∼80%
of CaKi-1 cells transfected with a control or S100A4-siRNA con-
struct survived hyperosmotic stress conditions (Figure 3C), while
only ∼65% of NFAT5-knockdown cells survived under these
conditions.
These results clearly indicate that both NFAT5 and S100A4 are
important for proliferation and migration ability of CaKi-1 cells.
NFAT5 is also important for survival during hyperosmotic stress,
while S100A4 is probably not essential under these conditions.
SIGNAL TRANSDUCTION PATHWAYS INVOLVED IN NFAT5 REGULATION
We next analyzed the activation of signal transduction path-
ways to elucidate the molecular basis for the high basal NFAT5
activity in CaKi-1 cells, compared to HK-2 cells. Various signal-
ing molecules are believed to mediate NFAT5 activity, among
them focal adhesion kinase (FAK) (Neuhofer et al., 2014), the
SRC kinase (Chen et al., 2011), often associated with FAK, and
the MAP kinases p38, ERK1/2, and JNK (Tsai et al., 2007).
We found that FAK and Src kinase are constitutively active in
CaKi-1 cells (Figure 4), and pharmacological inhibition of these
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FIGURE 2 | NFAT5-knockdown attenuates S100A4 expression in CaKi-1
cells. CaKi-1 cells were transfected with siRNA constructs for NFAT5
(siNFAT5), S100A4 (siS100A4) or with non-targeting siRNA (siControl) as
indicated. Cells were kept in isoosmotic medium (; 300 mosm/kg H2O)
or were exposed to hyperosmotic medium (; 500mosm/kg H2O).
Medium osmolality was elevated by addition of NaCl. (A) Cells were
incubated for 6 h (for NFAT5 determination) or 16 h (for S100A4 and AR
determination). Thereafter, RNA was extracted and the abundance of
NFAT5, S100A4, AR, and β-actin mRNA transcripts determined by
qRT-PCR as described in Methods. Relative mRNA abundance of NFAT5,
S100A4, or AR was normalized to that of β-actin to correct for differences
in RNA input. Data are means ± s.e.m. for n = 4 per point; #P < 0.05 vs.
siControl isoosmotic medium; ∗P < 0.05 vs. siControl hyperosmotic
medium. (B) Cells were incubated for 24 h and subsequently processed
for immunoblotting to determine expression of NFAT5, S100A4, and AR
as described in Methods. To demonstrate comparable protein loading, the
blots were also probed for β-actin. Representative blot from 4
independent experiments is shown.
kinases decreased NFAT5 activity and expression in CaKi-1 cells
(Figure 5). However, FAK and Src kinase are also constitutively
active in HK-2 cells (Figure 4), indicating that FAK and Src are
necessary, but alone not sufficient to account for the high NFAT5
activity in CaKi-1 cells. The MAP kinases p38, ERK1/2 (p44/42),
and c-jun-terminal kinase (JNK or p54/46) also regulate NFAT5
activity. p38 and JNK are inactive under isosmotic conditions and
are activated under hyperosmotic conditions in both CaKi-1 and
HK-2 cells. In contrast, ERK1/2 is constitutively active in CaKi-
1 cells, even under isosmotic conditions, but not in HK-2 cells.
Inhibition of ERK1/2, but not of p38 or JNK, decreased NFAT5
activity and expression under isosmotic conditions in CaKi-1
cells (Figures 5A,C), while inhibition of p38 and JNK impaired
osmolality-induced upregulation of NFAT5 activity and expres-
sion (Figures 5B,D). Accordingly, osmolality induced enhance-
ment of S100A4 was attenuated by pharmacological inhibition
of Src, FAK, ERK1/2, and p38 (Figure 5F). Surprisingly, JNK
inhibition attenuated hyperosmolality-induced S100A4 expres-
sion only slightly, the reason for this is unclear. Taken together,
these results indicate that constitutive activation of FAK and Src is
a prerequisite for NFAT5 expression, osmolality-induced activa-
tion of p38 and possibly JNK stimulate NFAT5 activation under
hyperosmotic conditions, and constitutive activation of ERK1/2
in CaKi-1 cells is probably responsible for the higher basal activity
and expression of NFAT5 in these cells compared with HK-2 cells.
DISCUSSION
The osmosensitive transcription factor NFAT5 has been associ-
ated with a variety of cancers. Here we present for the first time
evidence that NFAT5 is also involved in the development and pro-
gression of clear cell RCC. We found increased expression and
activity of NFAT5 in the RCC cell line CaKi-1 compared with
non-cancerous proximal tubule cells. Moreover, the metastasis-
associated protein S100A4, which has been previously identified
in colon cancer cells as an NFAT5 target gene, is very strongly
upregulated in CaKi-1 cells. Accordingly, knockdown of NFAT5
also decreased S100A4 expression. In control HK-2 cells, sub-
stantial NFAT5 expression and activity can be observed especially
during hyperosmotic stress, but S100A4 expression is still almost
undetectable under these conditions. This indicates that, in addi-
tion to regulation by NFAT5 activity, one or more further mecha-
nisms control S100A4 expression. The most probable mechanism
ismethylation of the S100A4 promoter in normal cells, which effi-
ciently prevents S100A4 expression, while the promoter is often
hypomethylated in cancer cells, as has been observed in colon
cancer cells (Chen et al., 2011). Accordingly, hypomethylation
of the S100A4 promoter has also been reported in RCC cells
(Lopez-Lago et al., 2010).
The role of S100A4 in RCC has not yet been studied in detail.
However, in the last years three clinical studies provided evidence
that high expression of S100A4 in primary tumors correlates
with metastasis and poor prognosis in RCC (Bandiera et al.,
2009; Wang et al., 2012; Yang et al., 2012). It has been proposed
that upregulation of S100A4 mediates epithelial-to-mesenchymal
transition, an initial step in the development of metastasis.
Accordingly, S100A4 is highly expressed in the metastatic RCC
cell line LM2, whilst knockdown decreases metastatic activity
(Lopez-Lago et al., 2010). In another study on RCC cells S100A4
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FIGURE 3 | Effect of NFAT5 and S100A4 knockdown on proliferation,
migration and survival of CaKi-1 cells. (A) Proliferation. CaKi-1 cells
(104 per case) were transfected with NFAT5-specific (siNFAT5),
S100A4-specific (siS100A4), or unspecific control (siControl) siRNA
constructs as described in Methods and seeded into one well of a
96-well plate. After 96 h, the cell number in each well was determined
by MTT assay. The number of viable cells treated with control siRNA
was defined as 100%. Data are means ± s.e.m. for n = 6; ∗P < 0.05 vs.
siControl. (B) Migration. CaKi-1 cells were treated with NFAT5-specific
(siNFAT5), S100A4-specific (siS100A4), or unspecific control (siControl)
siRNA constructs as described in Methods. After reaching confluency, the
cell layer was scratched with a 10μl pipette tip. Shown are
representative phase-contrast images of cells migrating into the wounded
area, immediately after scratching (0 h) and after an incubation time of
24 h. (C) Cell survival. CaKi-1 cells were treated with NFAT5-specific
(siNFAT5), S100A4-specific (siS100A4), or unspecific control (siControl)
siRNA constructs as described in Methods. Confluent cells were kept in
isoosmotic medium (; 300mosm/kg H2O) or were exposed to
hyperosmotic medium (; 600 mosm/kg H2O) for 24 h. Thereafter, the
cell number in each well was determined by MTT assay. Cell numbers in
isosmotic controls () were defined as 100%. Data are means ± s.e.m.
for n = 6; ∗P < 0.05 vs. siControl hyperosmotic medium.
stimulates the expression of Bcl-2, thereby attenuating apoptosis,
and MMP-2, which may also stimulate metastatic activity (Yang
et al., 2013).
Interestingly, S100A4 is expressed in the normal (i.e., non-
cancerous) kidney under physiological conditions (Rivard et al.,
2007). While it is not expressed in the isosmotic renal cortex,
S100A4 can be detected in the hyperosmotic renal medulla, where
its expression is even more stimulated during antidiuresis. In the
same study, the authors showed that S100A4 is strongly induced
under hyperosmotic conditions in inner medullary collecting
duct cells and that knockdown of S100A4 results in a 48 h-delay
in the onset of adaptation to hypertonic stress. These data sug-
gest that S100A4 is under physiological conditions part of the
osmoadaptive response that allows cells to tolerate the harsh con-
ditions in the renal inner medulla, however, in the present study
knockdown of S100A4 had no significant effect on CaKi-1 cell
survival during hyperosmotic stress. Whether S100A4 expression
in medullary collecting duct cells is driven by NFAT5 has not
been studied extensively, but the present results and other stud-
ies (Chen et al., 2009, 2011) strongly suggest that this is so. In
the present study, we also observed an “intact” osmoadaptive
response in CaKi-1 cells, meaning that NFAT5 mediates upreg-
ulation of osmoadaptive genes such as AR under hyperosmotic
conditions. The absence of this osmoadaptive response in NFAT5-
knockdown cells is probably the reason for the observed decreased
resistance to hyperosmotic conditions in these cells. CaKi-1 cells,
as a model for clear cell RCC, originate from the cortical proximal
tubule. Since this region is not exposed to hyperosmotic stress,
even during antidiuresis, osmolality-induced increase of cellular
NFAT5 activity may be not relevant as long as tumor cells remain
in the cortex. However, if cells of a growing tumor invade the renal
medullary region, these cells are exposed to hyperosmotic condi-
tions, which means that NFAT5 activity is increased. On the one
hand, this probably facilitates survival of tumor cells by elevating
the expression of S100A4 and other osmoadaptive genes like AR,
HSP70, or BGT-1; on the other, the elevated S100A4 expression
may also increase the metastatic activity of the tumor cells.
We observed also that NFAT5 knockdown decreases prolifera-
tion and migration of CaKi-1 cells. This is probably due, at least
in part, to the decreased S100A4 expression, since it has been
shown before that S100A4 promotes proliferation and migration
in renal carcinoma cells (Yang et al., 2013). However, it cannot
be ruled out that other NFAT5 target genes also stimulate tumor
development and metastasis. Especially the designated NFAT5
target gene HSP70 has been implicated in tumor cell prolifera-
tion, differentiation, and metastasis in a wide variety of cancers
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FIGURE 4 | Activation of signaling molecules in CaKi-1 and HK-2 cells.
CaKi-1 cells or HK-2 cells were incubated in isoosmotic medium (300
mosm/kg H2O) or hyperosmotic medium (500mosm/kg H2O). Medium
osmolality was elevated by addition of NaCl. Cells were incubated for 1 h
and subsequently lysed and abundance and phosphorylation status of FAK,
Src, JNK, ERK1/2, and p38 determined by immunoblotting as described in
Methods. Representative blots from 4 independent experiments are
shown.
(Ciocca and Calderwood, 2005). In non-small cell lung cancer,
NFAT5-mediated upregulation of HSP70 confers enhanced resis-
tance against apoptosis on tumor cells by inhibition of lysosomal
membrane permeabilization (Zhong et al., 2004; Mijatovic et al.,
2006). High expression of HSP70 has also been observed in RCC,
however, it is not clear whether HSP70-mediated inhibition of
apoptosis plays an important role in carcinogenesis and tumor
progression in RCC (Ramp et al., 2007). Other proposed NFAT5
target genes reportedly upregulated in RCC are Cyr61 (O’Connor
et al., 2007; Chintalapudi et al., 2008), and COX-2 (Chen et al.,
2004; Favale et al., 2009), whether NFAT5 is responsible for this
upregulation remains to be established.
We investigated osmolality-related signal transduction pro-
cesses and observed activation of the MAP kinases p38 and JNK
in both CaKi-1 and HK-2 cells in response to hyperosmotic
conditions. Our results indicate clearly that p38 is involved in
upregulation of NFAT5 activity and expression of the NFAT5 tar-
get gene S100A4 in CaKi-1 cells under these conditions, consistent
with previous reports (Lee et al., 2008; Roth et al., 2010). The
role of JNK for NFAT5 activation in CaKi-1 cells is more uncer-
tain. Inhibiton of JNK decreased NFAT5 activity, but expression
of S100A4 was only slightly and non-significantly decreased. The
reason for this discrepancy is not clear. Most reports in the lit-
erature deny an involvement of JNK in NFAT5 activation (Kultz
et al., 1997; Kojima et al., 2010; Roth et al., 2010).
In colon cancer cells NFAT5-mediated upregulation of S100A4
has been shown to be stimulated by Integrins and Src kinase
(Chen et al., 2011). Integrins are transmembrane receptors that
link the extracellular matrix to the intracellular actin cytoskele-
ton. Integrins can also initiate intracellular signaling events by
co-clustering with receptor- and non-receptor protein tyrosine
kinases (PTK). The non-receptor PTK Src often forms a dual
kinase complex with the non-receptor PTK FAK. Activated FAK-
Src complex promotes cell cycle progression, cell motility and
cell survival and is therefore often associated with the develop-
ment of cancer and metastasis (Mitra and Schlaepfer, 2006). It
was reported recently that Src and FAK are also expressed and
activated in patients with clear cell RCC (Qayyum et al., 2012).
Our own studies suggest that FAK is a positive regulator of NFAT5
expression in HEK 293 cells (Neuhofer et al., 2014). Accordingly,
the data of the present study provide evidence that NFAT5 expres-
sion and activity in CaKi-1 cells is positive regulated by Src and
FAK. Pharmacological inhibition of these kinases decreased cellu-
lar NFAT5 activity and expression of S100A4, and both kinases are
constitutively active in CaKi-1 cells. Since Src and FAK were also
constitutively active in HK-2 cells it is doubtful whether patho-
physiological upregulation of FAK-Src activity is responsible for
the elevated NFAT5 activity in RCC cells. In contrast, the MAP
kinase ERK1/2 was constitutively active in CaKi-1 cells, but not
in HK-2 cells. The role of ERK in NFAT5 activation is currently
controversial and may depend on the cell type (Tsai et al., 2007;
Morancho et al., 2008). In the present study, inhibition of ERK
in CaKi-1 cells attenuated both NFAT5 activation and expression
and also S100A4 expression, indicating that constitutive activa-
tion of this kinase is at least partly responsible for the high NFAT5
activity in RCC cells. Constitutive activation of the Ras-Raf-
MEK-ERK pathway, which mediates cellular responses to growth
signals under physiological conditions, has been observed in a
wide variety of cancers (Roberts and Der, 2007), but the molec-
ular mechanisms underlying this constitutive activation vary. An
important mechanism that has been identified in various tumor
entities is mutation of the BRAF gene, which results in expression
of a constitutive active B-Raf kinase and hence constitutive acti-
vation of ERK (Davies et al., 2002). However, since CaKi-1 cells
harbor a wildtype BRAF gene (Friday et al., 2008), this mecha-
nism can be excluded. A possible mechanism for constitutive ERK
activation in RCC cells is increased expression of transforming
growth factor-α (TGF-α), a ligand of the epidermal growth factor
receptor (EGFR). We have previously found in (non-cancerous)
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FIGURE 5 | Inhibition of FAK, Src, and MAP kinases attenuates NFAT5
activity in CaKi-1 cells. CaKi-1 cells were preincubated with the ERK1/2
inhibitor U0126 (U0; 10μM), the p38 inhibitor SB202190 (SB; 10μM), the JNK
inhibitor SP600125 (SP; 10μM), the FAK inhibitor PF-228 (PF; 5μM), the Src
inhibitor SrcI-1 (SrcI; 10μM), or vehicle DMSO (Veh) for 30min. Subsequently,
cells were incubated at 300 or 500 mosm/kg H2O as indicated. (A,B) CaKi-1
cells were transfected transiently with a reporter construct in which the SEAP
gene is under control of two TonE sites. After preincubation, the transfected
cells were incubated for 24 h at 300 or 500 mosm/kg H2O, as indicated.
Subsequently, SEAP activity was measured as described in Methods. Data
are means ± s.e.m. for n = 4 per point; ∗P < 0.05 vs. vehicle; #P < 0.05 vs.
vehicle hyperosmotic medium. (C–F) After preincubation, CaKi-1 cells were
incubated for 16 h at 300 or 500 mosm/kg H2O, as indicated. Subsequently,
RNA was extracted and the abundance of NFAT5, S100A4 and β-actin mRNA
transcripts was determined by qRT-PCR as described in Methods. Relative
mRNA abundance of NFAT5 and S100A4 was normalized to that of β-actin to
correct for differences in RNA input. Data are means ± s.e.m. for n = 4 per
point; *P < 0.05 vs. vehicle; #P < 0.05 vs. vehicle hyperosmotic medium.
renal collecting duct cells that maximal NFAT5 activation requires
TGF-α-mediated activation of the EGFR and the downstream
ERK kinase (Küper et al., 2009). Furthermore, overexpression of
TGF-α has long been known as a characteristic feature and has
been implicated with proliferation and vascularization of RCC
(Gomella et al., 1989; Gunaratnam et al., 2003; Pelletier et al.,
2009). We plan to investigate this potential mechanism for ERK
activation in RCC cells in future studies.
CONCLUSIONS
Taken together, the present study shows that the osmosensitive
transcription factor NFAT5 is expressed abundantly and is highly
active in the RCC cell line CaKi-1. NFAT5 stimulates the expres-
sion of the S100A4 metastasis factor in these cells, thereby regu-
lating proliferation and migration activity. These results indicate
that NFAT5 may contribute to the development and progression
of RCC.
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